[1. Devita, V. T., Lawrence, T. S., Rosenberg, S. A., 2015: Cancer: Principles and Practice of Oncology, 10th edn., Lippincott Williams and Wilkins, 2234 pp.]Search in Google Scholar
[2. Edwards, M. D., Pazzi, K. A., Gumerlock, P. H., 1993: cNras is activated infrequently in canine malignant lymphoma. Toxicol. Pathol., 21, 288-291.10.1177/019262339302100304]DOI öffnenSearch in Google Scholar
[3. Giantin, M., Aresu, L., Aricò, A., Gelain, M. E., Riondato, F., Comazzi. S. et al., 2013: Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: Might c-kit represent a therapeutic target ? Vet. Immunol. Immunopathol., 154, 153-159.10.1016/j.vetimm.2013.05.014]Search in Google Scholar
[4. Chorev, M., Carmel, L., 2012: The function of introns. Frontiers in genetics, 3, 1-15.10.3389/fgene.2012.00055]DOI öffnenSearch in Google Scholar
[5. Ito, D., Frantz, A. M., Modiano, J. F., 2014: Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications. Vet. Immunol. Immunopathol., 159, 192-201.10.1016/j.vetimm.2014.02.016]Search in Google Scholar
[6. London, C. A., Galli, S. J., Yuuki, T., Hu, Z. Q., Helfand, S. C., Geissler, E. N., 1999: Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene ckit. Exp. Hematol., 27, 689-697.10.1016/S0301-472X(98)00075-7]Search in Google Scholar
[7. Mayr, B., Winkler, G., Schaffner, G., Reifinger, M., Brem, G., 2002: N-ras mutation in a feline lymphoma. Low frequency of N-ras mutations in a series of feline, canine and bovine lymphomas. Vet. J., 163, 326-328.10.1053/tvjl.2001.069112090776]Search in Google Scholar
[8. Richter, A., Escobar, H. M., Gunther, K., Soller, J. T., Winkler, S., Nolte, I. et al., 2005: RAS gene hot-spot mutations in canine neoplasias. J. Hered., 96, 764−765.10.1093/jhered/esi12116251512]Search in Google Scholar
[9. Roman, E., Smith, A. G., 2011: Epidemiology of lymphomas. Histopathology, 58, 4-14.10.1111/j.1365-2559.2010.03696.x21261679]DOI öffnenSearch in Google Scholar
[10. Small, D., 2006: FLT3 mutations: biology and treatment. ASH Education Program Book, 2006, 178-184.10.1182/asheducation-2006.1.17817124058]Search in Google Scholar
[11. Stewart, B. W., Wild, C. P., 2014: World Cancer Report 2014. Lyon, International Agency for Research on Cancer, 630 pp.]Search in Google Scholar
[12. Suter, S. E., Small, G. W., Seiser, E. L., Thomas, R., Breen, M., Richards, K. L., 2011: FLT3 mutations in canine acute lymphocytic leukemia. BMC cancer, 11, 38.10.1186/1471-2407-11-38304016021272320]Search in Google Scholar
[13. Usher, S. G., Radford, A. D., Villiers, E. J., Blackwood, L., 2009: RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias. Exp. Hematol., 37, 65-77.10.1016/j.exphem.2008.09.00518977066]Search in Google Scholar
[14. Valli, E. V., San Myint, M., Barthel, A., Bienzle, D., Caswell, J., Colbatzky, F. et al., 2011: Classification of canine malignant lymphomas according to the World Health Organization criteria. Vet. Pathol., 48, 198-211.10.1177/030098581037942820861499]Search in Google Scholar
[15. Weinberg, R., 2013: The Biology of Cancer. Garland Science, 876 pp.10.1201/9780429258794]Search in Google Scholar